Publication:
A prospective European trial comparing laparotomy, laparoscopy, robotic-assisted, and transanal total mesorectal excision procedures in high-risk patients with rectal cancer: the RESET trial

dc.contributor.coauthorRouanet P., Guerrieri M., Lemercier P., Cotte E., Spinelli A., Gómez-Ruiz M., Wolthuis A., Bertani E., Dubois A., Carvello M., Paredes-Cotoré J.P., Di Candido F., Lorenzon L., Solis A., Coratti A., Rega D., Fernández C.C., Palmeri M., Khan J., Fernández-Hevia M., D'Hoore A., Coppola R., Denost Q., Aguirre-Allende I., Borda-Arrizabalaga N., Piessen G., Vincenti L., Özata I.H., Bianchi P.P., Valverde A., Rullier E., Kairaluoma M., Navarro-Sánchez A., Talvinder G., Ortúzar J.Z., Romain B., Conti J.A., Otero-Díez J.L., de Chaisemartin C., Germain A., Jafari M., Andriola V., Dumont F., Trigero-Cánovas D., Jiménez J.O., Petropoulou T., Fernández V.S., Brigand C., Mendoza-Moreno F., Fernández C.J., Martín-Pérez B., Caputo D., Varpe P., Perez D., Pellino G., Bensignor T., Lakkis Z., Sagias F., Celerier B., Dubois C., Douard R., Zver V., Lelong B., Perez S.L., Francis N.K., Faucheron J.-L., Brouquet A., Perna F., Rautio T.T., Takala H., Moreno E.K., Lepisto A., Borin S., Salvischiani L., Morelli L., Rohr S., Alcaide M.J., Kartheuser A., Quyn A., Aryal K., Ioannidis O., Hompes R., Crolla R., the RESET study group
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBalık, Emre
dc.contributor.kuauthorÖzoran, Emre
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:57:25Z
dc.date.issued2024
dc.description.abstractObjective: To compare total mesorectal excision (TME) techniques combined with sphincter-sparing procedure in high-risk patients (HRPs). Background: TME is the standard treatment for rectal cancer, but can be challenging in HRPs. The available surgical approaches must be compared, especially in HRPs. Methods: Prospective, observational, multicenter trial to compare laparotomy (OTME), laparoscopy (LTME), robotic-assisted surgery (RTME), and transanal surgery (TaTME) in HRPs. The composite primary outcome included circumferential radial margin (CRM) ≥1mm, TME grade II-III, and absence of Clavien-Dindo grade III-IV complications. Three propensity score analyses were performed (LTME vs. RTME, RTME vs. TaTME, LTME vs. TaTME). Results: 1078 HRPs (75% of men, median body mass index of 27 kg/m2, 50% of tumors in the lower third of the rectum) underwent surgery. The RTME and TaTME groups included patients with more advanced and lower tumors and coloanal anastomosis (Pandlt;0.001). Operative time was longer for RTME surgery (Pandlt;0.001). Conversion rate was similar for minimally invasive procedures (4.5%). The global R0 resection rate was 96% without difference among techniques. The primary outcome rates were 82.4%, 64.3%, 74.7%, and 80.3% for LTME, OTME, RTME, and TaTME, respectively. None achieved the expected success rate (85%), and propensity score analyses found no differences. Operative results were similar between high- and low-volume inclusion centers only for RTME. Conclusions: The RESET trial yielded high-quality results despite focusing on HRPs. Minimally invasive procedures showed similar sphincter-sparing procedure outcomes, but LTME included patients with more favorable tumors. Copyright © 2024 The Author(s).
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipConflicts of Interest and Source of Funding : RESET was endorsed by the European Society of Coloproctology (ESCP). Financial support was provided by Intuitive Surgical, Aubonne, Switzerland. RESET was designed and conducted independently at the Montpellier Cancer Institute. The funding institutions had no influence on the design or conduct of the study. PR received research and education grants from Intuitive Surgical. The other authors declare no other conflict of interest.
dc.identifier.doi10.1097/SLA.0000000000006534
dc.identifier.grantnoIntuitive Surgical
dc.identifier.issn0003-4932
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85204355500
dc.identifier.urihttps://doi.org/10.1097/SLA.0000000000006534
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27231
dc.keywordsLaparoscopy
dc.keywordsColectomy
dc.keywordsColorectal Cancer
dc.language.isoeng
dc.publisherWolters Kluwer Health
dc.relation.ispartofAnnals of Surgery
dc.subjectMedicine
dc.titleA prospective European trial comparing laparotomy, laparoscopy, robotic-assisted, and transanal total mesorectal excision procedures in high-risk patients with rectal cancer: the RESET trial
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorÖzoran, Emre
local.contributor.kuauthorBalık, Emre
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files